Geneva Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,765
Closed -$341K 83
2020
Q2
$341K Buy
+2,765
New +$341K 0.24% 70